Effects of 24 Months of Treatment With Romosozumab Followed by 12 Months of Denosumab or Placebo in Postmenopausal Women With Low Bone Mineral Density: A Randomized, Double-Blind, Phase 2, Parallel Group StudyMichael R. McClung, Andreas Grauer, Jacques P. Brown et al.|Journal of Bone and Mineral Research|2018Cited by 237
First-stage autosomal genome screen in extended pedigrees suggests genes predisposing to low bone mineral density on chromosomes 1p, 2p and 4qMarcella Devoto, LD Spotila, MP Whyte et al.|European Journal of Human Genetics|1998Cited by 221
Association of a Polymorphism in the <i>TNFR2</i> Gene with Low Bone Mineral DensityLoretta D. Spotila, Alan Tenenhouse, Henry Rodriguez et al.|Journal of Bone and Mineral Research|2000Cited by 45
Osteopenia in 37 Members of Seven Families: Analysis Based on a Model of Dominant InheritanceLoretta D. Spotila, Darwin J. Prockop, John Caminis et al.|Molecular Medicine|1996Cited by 40
Vitamin D Receptor Genotype is Not Associated with Bone Mineral Density in Three Ethnic/Regional GroupsLoretta D. Spotila, Harriet S. Tenenhouse, John Caminis et al.|Calcified Tissue International|1996Cited by 35